{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:18:08Z","timestamp":1789777088580,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T00:00:00Z","timestamp":1540944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011930","name":"Beijing Medical and Health Foundation","doi-asserted-by":"publisher","award":["YWJKJJHKYJJ-B17241-Q1"],"award-info":[{"award-number":["YWJKJJHKYJJ-B17241-Q1"]}],"id":[{"id":"10.13039\/501100011930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502697"],"award-info":[{"award-number":["81502697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81702767"],"award-info":[{"award-number":["81702767"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2016CFB374"],"award-info":[{"award-number":["2016CFB374"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2017CFB246"],"award-info":[{"award-number":["2017CFB246"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2018CFC874"],"award-info":[{"award-number":["2018CFC874"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.redox.2018.10.024","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T22:03:22Z","timestamp":1541196202000},"page":"451-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-\u03b3 in colon cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"YunYan","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-4986","authenticated-orcid":false,"given":"Mingxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pindong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0769-2874","authenticated-orcid":false,"given":"Xuanbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuandong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longchao","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingpin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.redox.2018.10.024_bib1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","article-title":"The immunobiology of cancer immunosurveillance and immunoediting","volume":"21","author":"Dunn","year":"2004","journal-title":"Immunity"},{"issue":"6024","key":"10.1016\/j.redox.2018.10.024_bib2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion","volume":"331","author":"Schreiber","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.redox.2018.10.024_bib3","doi-asserted-by":"crossref","first-page":"14607","DOI":"10.1038\/ncomms14607","article-title":"IFN-gamma is required for cytotoxic T cell-dependent cancer genome immunoediting","volume":"8","author":"Takeda","year":"2017","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.redox.2018.10.024_bib4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1535-7163.MCT-11-0758","article-title":"Selective targeting of interferon gamma to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth","volume":"11","author":"Bansal","year":"2012","journal-title":"Mol. Cancer Ther."},{"issue":"19","key":"10.1016\/j.redox.2018.10.024_bib5","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/1078-0432.CCR-11-0482","article-title":"The two faces of interferon-gamma in cancer","volume":"17","author":"Zaidi","year":"2011","journal-title":"Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.redox.2018.10.024_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.immuni.2016.01.019","article-title":"A common variant in the adaptor mal regulates interferon gamma signaling","volume":"44","author":"Ni Cheallaigh","year":"2016","journal-title":"Immunity"},{"issue":"40","key":"10.1016\/j.redox.2018.10.024_bib7","doi-asserted-by":"crossref","first-page":"41679","DOI":"10.1074\/jbc.M406413200","article-title":"Alternative activation of STAT1 and STAT3 in response to interferon-gamma","volume":"279","author":"Qing","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.redox.2018.10.024_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/2159-8290.CD-16-1439","article-title":"JAK mutations as escape mechanisms to Anti-PD-1 therapy","volume":"7","author":"Marabelle","year":"2017","journal-title":"Cancer Discov."},{"issue":"5","key":"10.1016\/j.redox.2018.10.024_bib9","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI31405","article-title":"Immune surveillance of tumors","volume":"117","author":"Swann","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.redox.2018.10.024_bib10","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.4049\/jimmunol.180.6.3766","article-title":"Modulation of the tumor cell phenotype by IFN-gamma results in resistance of uveal melanoma cells to granule-mediated lysis by cytotoxic lymphocytes","volume":"180","author":"Hallermalm","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.redox.2018.10.024_bib11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.redox.2018.10.024_bib12","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/0008-5472.CAN-12-3696","article-title":"The emerging \"hallmarks\" of metabolic reprogramming and immune evasion: distinct or linked?","volume":"73","author":"Kareva","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.redox.2018.10.024_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13046-015-0221-y","article-title":"Metabolic reprogramming: the emerging concept and associated therapeutic strategies","volume":"34","author":"Yoshida","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5930","key":"10.1016\/j.redox.2018.10.024_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.redox.2018.10.024_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0005-2728(77)90166-9","article-title":"Pyruvate transport in tumour-cell mitochondria","volume":"460","author":"Eboli","year":"1977","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.redox.2018.10.024_bib16","first-page":"5068","article-title":"Transport of pyruvate in mitochondria from different tumor cells","volume":"43","author":"Paradies","year":"1983","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.redox.2018.10.024_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol. Cell"},{"issue":"3","key":"10.1016\/j.redox.2018.10.024_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.redox.2018.10.024_bib19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/nprot.2016.074","article-title":"In vivo monitoring of cellular energy metabolism using SoNar, a highly responsive sensor for NAD(+)\/NADH redox state","volume":"11","author":"Zhao","year":"2016","journal-title":"Nat. Protoc."},{"issue":"6","key":"10.1016\/j.redox.2018.10.024_bib20","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1074\/jbc.M307774200","article-title":"STAT1-induced apoptosis is mediated by caspases 2, 3, and 7","volume":"279","author":"Sironi","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.redox.2018.10.024_bib21","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1158\/1535-7163.MCT-09-1169","article-title":"IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis","volume":"9","author":"Ning","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.redox.2018.10.024_bib22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cellsig.2012.01.008","article-title":"Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling","volume":"24","author":"Ray","year":"2012","journal-title":"Cell Signal"},{"issue":"3","key":"10.1016\/j.redox.2018.10.024_bib23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","article-title":"Reactive oxygen species in cancer cells: live by the sword, die by the sword","volume":"10","author":"Schumacker","year":"2006","journal-title":"Cancer Cell"},{"issue":"6060","key":"10.1016\/j.redox.2018.10.024_bib24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.1215637","article-title":"Cell biology. Warburg effect and redox balance","volume":"334","author":"Hamanaka","year":"2011","journal-title":"Science"},{"issue":"6282","key":"10.1016\/j.redox.2018.10.024_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.aad4017","article-title":"Complementation of mitochondrial electron transport chain by manipulation of the NAD+\/NADH ratio","volume":"352","author":"Titov","year":"2016","journal-title":"Science"},{"issue":"5573","key":"10.1016\/j.redox.2018.10.024_bib26","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.redox.2018.10.024_bib27","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/onc.2015.150","article-title":"JAK kinase in solid tumors: emerging opportunities and challenges","volume":"35","author":"Buchert","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.redox.2018.10.024_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1186\/s12885-016-2941-6","article-title":"MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718307389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231718307389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:08:05Z","timestamp":1761977285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231718307389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"alternative-id":["S2213231718307389"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2018.10.024","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-\u03b3 in colon cancer","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2018.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}